Diary Observational Study in Hemophilia (DOSE): Evaluation of Enrolled Population and Overall Diary Data Capture in Congenital Hemophilia Patients with Alloantibody Inhibitors.

被引：0
|
作者：
Young, Guy [2 ]
Shapiro, Amy D. [1 ]
Valentino, Leonard A. [3 ]
Kessler, Craig M. [4 ]
Cooper, David L. [5 ]
机构：
[1] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA
[2] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[3] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[4] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[5] Novo Nordisk Inc, Med Affairs, Princeton, NJ USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1352 / 1353
页数：2
相关论文
共 19 条
  • [1] Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE)
    Recht, Michael
    Neufeld, Ellis J.
    Sharma, Vivek R.
    Salem, Caitlyn T.
    Pickard, A. Simon
    Gut, Robert Z.
    Cooper, David L.
    VALUE IN HEALTH, 2014, 17 (06) : 744 - 748
  • [2] Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)
    Young, Guy
    Solem, Caitlyn T.
    Hoffman, Kate
    Kabawat, Jenna
    Pickard, A. Simon
    Gut, Robert Z.
    Cooper, David L.
    JOURNAL OF BLOOD MEDICINE, 2012, 3 : 131 - 138
  • [3] A COMPARISON OF DOSING OF RECOMBINANT FACTOR VIIa (rFVIIa) IN PEDIATRIC VERSUS ADULT PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHwI): PRESCRIPTION AND ACTUAL DATA FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)
    Gruppo, Ralph
    Kessler, Craig
    Neufeld, Ellis
    Cooper, David
    Carr, Marcus
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 810 - 810
  • [4] DAILY ASSESSMENT OF OUTCOMES CAPTURING HOME TREATMENT OF CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI): DESIGN, DISPOSITION AND IMPLICATIONS OF THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)
    Cooper, D. L.
    Young, G.
    Wilke, C. T.
    Hoffman, K.
    Kabawat, J.
    Pickard, A. S.
    VALUE IN HEALTH, 2010, 13 (03) : A214 - A214
  • [5] Safety of Recombinant Activated Factor VII (rFVIIa) in Patients with Congenital Hemophilia with Inhibitors: Overall Dose Exposure and Intervals Following >240 Mcg/Kg Doses Across Trial, Registry and Diary Studies
    Shapiro, Amy D.
    Neufeld, Ellis J.
    Blanchette, Victor S.
    Chambost, Herve
    Salaj, Peter
    Gut, Robert Z.
    Cooper, David L.
    BLOOD, 2011, 118 (21) : 1426 - 1426
  • [6] Capturing daily home treatment and quality of life assessments in Congenital Hemophilia with Inhibitors (CHwI): design, disposition and implications of the Dosing Observational Study in hemophilia (DOSE)
    Young, G.
    Cooper, D. L.
    Hoffman, K.
    Kabawat, J.
    Wilke, C. T.
    HAEMOPHILIA, 2010, 16 : 146 - 146
  • [7] A comparison of prescribed and actual recombinant factor VIIa (rFVIIa) dosing in pediatric versus adult patients with congenital hemophilia with inhibitors (CHwI): analysis of the dosing observational study in hemophilia (DOSE)
    Gruppo, R.
    Kessler, C.
    Neufeld, E.
    Shapiro, A.
    Cooper, D.
    Carr, M., Jr.
    HAEMOPHILIA, 2010, 16 : 73 - 73
  • [8] Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia
    Neufeld, Ellis J.
    Recht, Michael
    Sabio, Hernan
    Saxena, Kapil
    Solem, Caitlyn T.
    Pickard, A. Simon
    Gut, Robert Z.
    Cooper, David L.
    VALUE IN HEALTH, 2012, 15 (06) : 916 - 925
  • [9] Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing for acute bleeds in patients with congenital hemophilia with inhibitors (CHwI): results from the dosing observational study in hemophilia (DOSE)
    Young, G.
    Walsh, C.
    Gruppo, R.
    Cooper, D.
    HAEMOPHILIA, 2010, 16 : 80 - 80
  • [10] IMPACT OF ACUTE BLEEDING AND ADMINISTRATION OF BYPASSING AGENTS (BPA) ON DAILY ACTIVITIES OF PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR CAREGIVERS AND FAMILIES: OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)
    Recht, M.
    Neufeld, E. J.
    Sharma, V
    Cooper, D. L.
    Wilke, C. T.
    Pickard, A. S.
    Gut, R.
    VALUE IN HEALTH, 2010, 13 (03) : A214 - A214
12